To The Moon

Sign Up

ARKG Investment Tracker

Source from：official website ARKG is an exchange-traded fund (ETF) managed by Cathie Wood, focusing on stocks related to the genomic revolution. The "ARK Genomic Revolution Fund Guru Tracker" is based on ARKG's daily disclosure reports, helping investors track its investment strategy.

    • ARKG Investment TrackerARKG Investment Tracker
      ·07:13
      ARKG Investment Tracker position change: Decreased position in Vertex Pharmaceuticals by 310 shares, the number of shares held decreased 1.17% compared to the previous period and now represents 0.98% of the total position.
      135Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·07:13
      ARKG Investment Tracker position change: Decreased position in CareDx by 25,400 shares, the number of shares held decreased 1.17% compared to the previous period and now represents 3.4% of the total position.
      118Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·07:13
      ARKG Investment Tracker position change: Decreased position in Intellia Therapeutics by 35,960 shares, the number of shares held decreased 1.17% compared to the previous period and now represents 3.15% of the total position.
      462Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·07:13
      ARKG Investment Tracker position change: Decreased position in Butterfly Network Inc by 74,420 shares, the number of shares held decreased 1.17% compared to the previous period and now represents 1.53% of the total position.
      305Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·07:13
      ARKG Investment Tracker position change: Decreased position in Veeva by 35,473 shares, the number of shares held decreased 85.03% compared to the previous period and now represents 0.091% of the total position.
      196Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·07:13
      ARKG Investment Tracker position change: Decreased position in Amgen by 530 shares, the number of shares held decreased 1.15% compared to the previous period and now represents 1.36% of the total position.
      56Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·07:13
      ARKG Investment Tracker position change: Decreased position in Adaptive Biotechnologies Corp by 25,670 shares, the number of shares held decreased 1.17% compared to the previous period and now represents 2.77% of the total position.
      303Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·07:13
      ARKG Investment Tracker position change: Decreased position in Beam Therapeutics, Inc. by 26,880 shares, the number of shares held decreased 1.17% compared to the previous period and now represents 5.04% of the total position.
      297Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·07:13
      ARKG Investment Tracker position change: Decreased position in Twist Bioscience Corp by 28,862 shares, the number of shares held decreased 1.35% compared to the previous period and now represents 8.86% of the total position.
      92Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·07:13
      ARKG Investment Tracker position change: Decreased position in Natera by 2,820 shares, the number of shares held decreased 1.17% compared to the previous period and now represents 4.11% of the total position.
      233Comment
      Report
      • empty
        No followers yet
       
       
       
       

      Most Discussed